静配中心等核心设备产品
Search documents
健麾信息拟收购博科国信38%股权
Bei Jing Shang Bao· 2026-02-05 12:09
Core Viewpoint - The company, Jianhui Information, plans to acquire additional equity in Boke Guoxin (Wuhan) Technology Co., Ltd., increasing its ownership from 32% to 70%, thereby making it a subsidiary and consolidating it into the company's financial statements [1] Group 1: Acquisition Details - Jianhui Information will purchase 16.75%, 13.25%, 4%, and 4% equity stakes from four entities for a total of 37.687 million yuan [1] - Post-transaction, the remaining 30% of Boke Guoxin will be held by Zhou Xiaoping [1] Group 2: Strategic Implications - This acquisition is a key move for the company to implement its intelligent development strategy and enhance industry chain collaboration [1] - The increased stake will allow for better integration of technology advantages in automation hardware, software platforms, and medical AI [1] - The collaboration aims to create a more competitive overall solution for smart hospitals and regional healthcare [1]
健麾信息(605186.SH):拟收购博科国信(武汉)部分股权 将提升对其的持股比例并实现控股
Ge Long Hui A P P· 2026-02-05 10:16
Core Viewpoint - The company, Jianhui Information, is acquiring additional equity in Boke Guoxin (Wuhan) Technology Co., Ltd., increasing its ownership from 32% to 70%, which will make Boke Guoxin a subsidiary and included in the consolidated financial statements [1] Group 1: Transaction Details - The company plans to acquire 16.75%, 13.25%, 4.00%, and 4.00% equity stakes from Zhou Xiaoping, Ze Pu Investment, Boke Yixin, and Boke Guoxin for a total of RMB 37.6875 million, 22.8563 million, 6.375 million, and 6.7914 million respectively [1] - After the transaction, Zhou Xiaoping will hold the remaining 30% of Boke Guoxin [1] Group 2: Strategic Importance - This transaction is a key measure for the company to implement its intelligent development strategy and deepen industry chain collaboration [1] - Increasing the stake in Boke Guoxin will facilitate the integration of both parties' technological advantages in automation hardware, software platforms, and medical AI [1] Group 3: Market Expansion and Innovation - Boke Guoxin is a member of the China Healthcare Information Interconnection Technology Alliance and has extensive development experience with the HL7 international medical information standards, which will aid the company's overseas market expansion [2] - The acquisition will accelerate the company's business development in emerging markets such as county-level medical communities and data governance for medical institutions [2] - The integration of business and resource sharing is expected to enhance the company's technological innovation capabilities and market responsiveness, laying a solid foundation for future performance growth [2]
健麾信息:拟收购博科国信(武汉)部分股权 将提升对其的持股比例并实现控股
Ge Long Hui· 2026-02-05 10:04
Core Viewpoint - The company, Jianhui Information, plans to acquire additional equity in Boke Guoxin (Wuhan) Technology Co., Ltd., increasing its ownership from 32% to 70%, thereby making it a subsidiary and consolidating its financials [1][2] Group 1: Acquisition Details - The company intends to purchase 16.75%, 13.25%, 4.00%, and 4.00% equity stakes from Zhou Xiaoping, Ze Pu Investment, Boke Yixin, and Boke Guoxin for a total of RMB 37.6875 million, 22.8563 million, 6.375 million, and 6.7914 million respectively [1] - Post-transaction, Zhou Xiaoping will retain the remaining 30% equity in the target company [1] Group 2: Strategic Importance - This acquisition is a key move for the company to implement its intelligent development strategy and deepen industry chain collaboration [1] - By increasing its stake, the company aims to integrate its automation hardware, software platforms, and medical AI capabilities with those of the target company [1] Group 3: Market Expansion and Innovation - The target company is a member of the China Healthcare Information Interconnection Technology Alliance and has extensive experience with the HL7 international medical information standards, which will facilitate the company's expansion into overseas markets [2] - The transaction is expected to accelerate the company's business development in emerging markets such as county-level medical communities and data governance for medical institutions [2] - Through business integration and resource sharing, the company aims to enhance its technological innovation capabilities and market responsiveness, laying a solid foundation for future performance growth [2]